Stock comparison
Argan
Cintas
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
AGX
Argan
Market cap
$9.16B
Sector
Industrials
CTAS
Cintas
Market cap
$69.19B
Sector
Industrials
Overall winner
Cintas CTAS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | AGX | CTAS | Winner |
|---|---|---|---|
| Warren Buffett | 58C | 77B | CTAS |
| Benjamin Graham | 78B | 84A | CTAS |
| Philip Fisher | 69B | 72B | CTAS |
| Peter Lynch | 71B | 68B | AGX |
| Joel Greenblatt | 65C | 69B | CTAS |
| Charlie Munger | 57C | 80A | CTAS |
| Terry Smith | 62C | 75B | CTAS |
Side-by-side metrics
| Metric | AGX | CTAS |
|---|---|---|
| Market cap | $9.16B | $69.19B |
| P/E (TTM) | 72.8x | 34.9x |
| EV/EBIT | 72.4x | 29.7x |
| ROIC (TTM) | 23.97% | 23.17% |
| Gross margin | 20.5% | 50.36% |
| Net margin | 14.59% | 17.57% |
| Revenue CAGR 5y | 16.7% | 9.79% |
| EPS CAGR 5y | 42.43% | 14.24% |
| Debt / Equity | 0.0x | 0.6x |
| Dividend yield | 0.26% | 1.07% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AGX leads on
- Debt / Equity0.0xvs 0.6x+98%
- EPS CAGR 5y42.43%vs 14.24%+66%
- Revenue CAGR 5y16.7%vs 9.79%+41%
CTAS leads on
- Market cap$69.19Bvs $9.16B+87%
- Dividend yield1.07%vs 0.26%+76%
- Gross margin50.36%vs 20.5%+59%
- EV/EBIT29.7xvs 72.4x+59%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.